VIAL
Compound comparison

Anastrozole vs Testosterone Cypionate

Anastrozole and Testosterone Cypionate are both hormone compounds evaluated on Vial: Anastrozole is FDA approved with FDA-approval-level clinical evidence, and Testosterone Cypionate is FDA approved with FDA-approval-level clinical evidence, offered by 13 and 25 verified providers respectively.

Vial summary · compiled from public records

At a glance

Anastrozole

Sold as Arimidex

Category
Hormone
FDA / legal status
FDA Approved
Route
Oral
13providers on Vial →

Testosterone Cypionate

Sold as Depo-Testosterone

Category
Hormone
FDA / legal status
FDA Approved
Route
Intramuscular, subcutaneous
25providers on Vial →

Side by side

FieldAnastrozoleTestosterone Cypionate
CategoryHormoneHormone
Brand namesArimidexDepo-Testosterone
FDA / legal statusFDA ApprovedFDA Approved
Evidence tierFDA ApprovedFDA Approved
Administration routeOralIntramuscular, subcutaneous
Compounding accessFDA-approved product, dispensed by prescriptionFDA-approved product, dispensed by prescription
Providers on Vial13 listed25 listed
Typical price band$$ to $$$$$ to $$$

Verified providers offering each

Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.

85+ High Confidence70 to 84 Well Documented50 to 69 Limited ConfidenceUnder 50 Flagged

About each compound

About Anastrozole

Anastrozole is an FDA-approved aromatase inhibitor used in TRT protocols to manage estradiol levels that become elevated during testosterone therapy. By blocking aromatase enzyme activity, it prevents excess conversion of testosterone to estradiol, mitigating estrogenic side effects such as gynecomastia and water retention. It is one of the most commonly prescribed ancillary medications in men's health and hormone optimization.

About Testosterone Cypionate

A synthetic ester of testosterone, testosterone cypionate is an intramuscularly or subcutaneously administered androgen that provides sustained release of the hormone over approximately one to two weeks. It binds to androgen receptors throughout the body, promoting protein synthesis, muscle development, bone density maintenance, and secondary sex characteristics. The compound is primarily used in the treatment of male hypogonadism and as a component of gender-affirming hormone therapy.

Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

Related compound comparisons

Other comparisons in the same category.

All compound comparisons →